Cardlytics, Inc.
corporate_fare Company Profile
Cardlytics, Inc. (NASDAQ:CDLX) is a publicly traded company in the Technology sector. Wiseek has independently scored 22 items for CDLX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for CDLX spans 8-K, 10-Q, 4, DEFA14A.
Recent high-impact activity:
- Cardlytics Cuts 15% of Workforce, Targets $12.2M Annualized Expense Savings
- Cardlytics 10-Q: $29.9M Cash Against $194.7M Debt, Goodwill Impairment Risk Flagged
- Cardlytics Q3 Revenue Falls 30% to $32.9M; Q4 Guidance Signals Further Decline
- Cardlytics Posts $32.9M in Q3 Revenue
- Cardlytics Resolves Founder Indemnification Claim for $6.4M, Secures Insurance Rights
Financial Snapshot
Short Interest & Short Volume
5.68 days to coverFINRA reported short interest of 475,225 shares in CDLX as of the October 30, 2026 settlement, a 4.6% decrease from the prior period — about 5.7 days to cover at its recent average daily volume. On November 20, 2026, 75.5% of CDLX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.